Concepedia

Mariano Severgnini

MS

Statistics

Publications

47

Citations

4.1K

H-Index

31

Active since

2002

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Massachusetts General Hospital

Dana-Farber Brigham Cancer Center

Mariano Severgnini is an author at Dana-Farber Cancer Institute specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

2002–2023

47

Publications

47

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 594 citations · Full text

Medicine, Immunology, Oncology +15

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters et al. · Clinical Cancer Research · 2020 · 257 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon et al. · Cancer · 2017 · 223 citations · Full text

Medicine, Oncology, Pharmacology +12

Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner et al. · Journal for ImmunoTherapy of Cancer · 2018 · 193 citations · Full text

Life Sciences, Immunology, Oncology +17

A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development

Mariano Severgnini, Jennifer Sherman, Alfica Sehgal et al. · Cytotechnology · 2011 · 173 citations

Life Sciences, Molecular Biology, Hepatology +11

1–5 of 47